Browsing byAuthorDore, GJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 3 to 9 of 9< previous 
Issue DateTitleAuthor(s)
2009-09-01Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot studyDoab, A; Topp, L; Day, CA; Dore, GJ; Maher, L
2016-01-01Concordance between missed days of hepatitis B virus anti-viral therapy and virological breakthroughSheppard-Law, SJ; Kermeen, M; Holdaway, S; Zekry, A; George, J; Dore, GJ; Maher, L
2008-03-01Experience of hepatitis C testing among injecting drug users in Sydney, AustraliaDay, CA; White, B; Thein, HH; Doab, A; Dore, GJ; Bates, A; Holden, J; Maher, L
2017-01-01Factors associated with HBV virological breakthroughSheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; Zekry, A; Dore, GJ; George, J; Maher, L
2011-04-18Predictors of deferral of treatment for hepatitis C infection in Australian clinicsGidding, HF; Law, MG; Amin, J; MacDonald, GA; Sasadeusz, JJ; Jones, TL; Strasser, SI; George, J; Dore, GJ
2021-07-06SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.Tea, F; Ospina Stella, A; Aggarwal, A; Ross Darley, D; Pilli, D; Vitale, D; Merheb, V; Lee, FXZ; Cunningham, P; Walker, GJ; Fichter, C; Brown, DA; Rawlinson, WD; Isaacs, SR; Mathivanan, V; Hoffmann, M; Pöhlman, S; Mazigi, O; Christ, D; Dwyer, DE; Rockett, RJ; Sintchenko, V; Hoad, VC; Irving, DO; Dore, GJ; Gosbell, IB; Kelleher, AD; Matthews, GV; Brilot, F; Turville, SG
2023-04Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.Grebely, J; Gilliver, R; McNaughton, T; Conway, A; Cunningham, E; Henderson, C; Hadlow, B; Molloy, K; Doab, A; Tillakeratne, S; Pepolim, L; Harrod, ME; Dore, GJ; Read, P